Fig. 3From: Preclinical in vivo application of 152Tb-DOTANOC: a radiolanthanide for PET imagingTumor-to-background ratios of 177Lu-DOTANOC obtained after injection of three different molar amounts of injected peptide (0.5, 2.5, and 5.0 nmol). a Tumor-to-blood ratios, b tumor-to-liver ratios, and c tumor-to-kidney ratiosBack to article page